APO Research
Talk to an analyst

APO RESEARCH · REPORT

Isavuconazonium Sulfate Medicine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Isavuconazonium Sulfate Medicine Market Outlook and Growth Opportunities 2026

27 December 2025196 pages

Choose your research edition.

Industry ResearchIsavuconazonium Sulfate Medicine Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Isavuconazonium Sulfate Medicine Industry Growth and Trends Forecast to 203264 pages · $3,450 USDMarket StructureGlobal Isavuconazonium Sulfate Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Isavuconazonium Sulfate Medicine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Isavuconazonium Sulfate Medicine Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Isavuconazonium Sulfate Medicine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Isavuconazonium Sulfate Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Isavuconazonium Sulfate Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Isavuconazonium Sulfate Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Isavuconazonium Sulfate Medicine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Isavuconazonium Sulfate Medicine market include Astellas Pharma, Basilea Pharmaceutica and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Isavuconazonium Sulfate Medicine market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Isavuconazonium Sulfate Medicine and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Isavuconazonium Sulfate Medicine revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Isavuconazonium Sulfate Medicine market.

Isavuconazonium Sulfate Medicine Segment by Company

Astellas Pharma

Basilea Pharmaceutica

Pfizer

Isavuconazonium Sulfate Medicine Segment by Type

Injections

Capsules

Isavuconazonium Sulfate Medicine Segment by Application

Hospital Pharmacy

Retail Pharmacy

Isavuconazonium Sulfate Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Isavuconazonium Sulfate Medicine status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Isavuconazonium Sulfate Medicine key companies, revenue, market share, and recent developments.

3. To split the Isavuconazonium Sulfate Medicine breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Isavuconazonium Sulfate Medicine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Isavuconazonium Sulfate Medicine significant trends, drivers, influence factors in global and regions.

6. To analyze Isavuconazonium Sulfate Medicine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Isavuconazonium Sulfate Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Isavuconazonium Sulfate Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Isavuconazonium Sulfate Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Isavuconazonium Sulfate Medicine industry.

Chapter 3: Detailed analysis of Isavuconazonium Sulfate Medicine company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Isavuconazonium Sulfate Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Isavuconazonium Sulfate Medicine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Isavuconazonium Sulfate Medicine Industry Trends Table 2. Isavuconazonium Sulfate Medicine Industry Drivers Table 3. Isavuconazonium Sulfate Medicine Industry Opportunities and Challenges Table 4. Isavuconazonium Sulfate Medicine Industry Restraints Table 5. Global Isavuconazonium Sulfate Medicine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Isavuconazonium Sulfate Medicine Revenue Share by Company (2021-2026) Table 7. Global Isavuconazonium Sulfate Medicine Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Isavuconazonium Sulfate Medicine Key Company Manufacturing Base & Headquarters Table 9. Global Isavuconazonium Sulfate Medicine Company, Product Type & Application Table 10. Global Isavuconazonium Sulfate Medicine Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Isavuconazonium Sulfate Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Injections Table 15. Significant Companies of Capsules Table 16. Global Isavuconazonium Sulfate Medicine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Isavuconazonium Sulfate Medicine Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Isavuconazonium Sulfate Medicine Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Isavuconazonium Sulfate Medicine Sales Value Share by Type (2021-2026) Table 20. Global Isavuconazonium Sulfate Medicine Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Hospital Pharmacy Table 22. Significant Companies of Retail Pharmacy Table 23. Global Isavuconazonium Sulfate Medicine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Isavuconazonium Sulfate Medicine Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Isavuconazonium Sulfate Medicine Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Isavuconazonium Sulfate Medicine Sales Value Share by Application (2021-2026) Table 27. Global Isavuconazonium Sulfate Medicine Sales Value Share by Application (2027-2032) Table 28. Global Isavuconazonium Sulfate Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Isavuconazonium Sulfate Medicine Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Isavuconazonium Sulfate Medicine Sales Value Share by Region (2021-2026) Table 31. Global Isavuconazonium Sulfate Medicine Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Isavuconazonium Sulfate Medicine Sales Value Share by Region (2027-2032) Table 33. Global Isavuconazonium Sulfate Medicine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Isavuconazonium Sulfate Medicine Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Isavuconazonium Sulfate Medicine Sales Value Market Share by Country (2021-2026) Table 36. Global Isavuconazonium Sulfate Medicine Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Isavuconazonium Sulfate Medicine Sales Value Market Share by Country (2027-2032) Table 38. Astellas Pharma Company Information Table 39. Astellas Pharma Business Overview Table 40. Astellas Pharma Isavuconazonium Sulfate Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Astellas Pharma Isavuconazonium Sulfate Medicine Product Portfolio Table 42. Astellas Pharma Recent Development Table 43. Basilea Pharmaceutica Company Information Table 44. Basilea Pharmaceutica Business Overview Table 45. Basilea Pharmaceutica Isavuconazonium Sulfate Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Basilea Pharmaceutica Isavuconazonium Sulfate Medicine Product Portfolio Table 47. Basilea Pharmaceutica Recent Development Table 48. Pfizer Company Information Table 49. Pfizer Business Overview Table 50. Pfizer Isavuconazonium Sulfate Medicine Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Pfizer Isavuconazonium Sulfate Medicine Product Portfolio Table 52. Pfizer Recent Development Table 53. Research Programs/Design for This Report Table 54. Authors List of This Report Table 55. Secondary Sources Table 56. Primary Sources List of Figures Figure 1. Isavuconazonium Sulfate Medicine Product Image Figure 2. Global Isavuconazonium Sulfate Medicine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Isavuconazonium Sulfate Medicine Market Size (2021-2032) & (US$ Million) Figure 4. Global Isavuconazonium Sulfate Medicine Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Injections Image Figure 8. Capsules Image Figure 9. Global Isavuconazonium Sulfate Medicine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Isavuconazonium Sulfate Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Isavuconazonium Sulfate Medicine Sales Value Share by Type (2021-2032) Figure 12. Hospital Pharmacy Image Figure 13. Retail Pharmacy Image Figure 14. Global Isavuconazonium Sulfate Medicine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Isavuconazonium Sulfate Medicine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Isavuconazonium Sulfate Medicine Sales Value Share by Application (2021-2032) Figure 17. Global Isavuconazonium Sulfate Medicine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Isavuconazonium Sulfate Medicine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Isavuconazonium Sulfate Medicine Sales Value (2021-2032) & (US$ Million) Figure 20. North America Isavuconazonium Sulfate Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Isavuconazonium Sulfate Medicine Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Isavuconazonium Sulfate Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Isavuconazonium Sulfate Medicine Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Isavuconazonium Sulfate Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Isavuconazonium Sulfate Medicine Sales Value (2021-2032) & (US$ Million) Figure 26. South America Isavuconazonium Sulfate Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Isavuconazonium Sulfate Medicine Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Isavuconazonium Sulfate Medicine Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Injections
  • Capsules
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
Companies covered
  • Astellas Pharma
  • Basilea Pharmaceutica
  • Pfizer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Isavuconazonium Sulfate Medicine Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Isavuconazonium Sulfate Medicine Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Isavuconazonium Sulfate Medicine Market Dynamics
  1. 2.1 Isavuconazonium Sulfate Medicine Industry Trends
  2. 2.2 Isavuconazonium Sulfate Medicine Industry Drivers
  3. 2.3 Isavuconazonium Sulfate Medicine Industry Opportunities and Challenges
  4. 2.4 Isavuconazonium Sulfate Medicine Industry Restraints
3 Isavuconazonium Sulfate Medicine Market by Company
  1. 3.1 Global Isavuconazonium Sulfate Medicine Company Revenue Ranking in 2025
  2. 3.2 Global Isavuconazonium Sulfate Medicine Revenue by Company (2021-2026)
  3. 3.3 Global Isavuconazonium Sulfate Medicine Company Ranking (2024-2026)
  4. 3.4 Global Isavuconazonium Sulfate Medicine Company Manufacturing Base and Headquarters
  5. 3.5 Global Isavuconazonium Sulfate Medicine Company Product Type and Application
  6. 3.6 Global Isavuconazonium Sulfate Medicine Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Isavuconazonium Sulfate Medicine Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Isavuconazonium Sulfate Medicine Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Isavuconazonium Sulfate Medicine Market by Type
  1. 4.1 Isavuconazonium Sulfate Medicine Type Introduction
  2. 4.1.1 Injections
  3. 4.1.2 Capsules
  4. 4.2 Global Isavuconazonium Sulfate Medicine Sales Value by Type
  5. 4.2.1 Global Isavuconazonium Sulfate Medicine Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Isavuconazonium Sulfate Medicine Sales Value by Type (2021-2032)
  7. 4.2.3 Global Isavuconazonium Sulfate Medicine Sales Value Share by Type (2021-2032)
5 Isavuconazonium Sulfate Medicine Market by Application
  1. 5.1 Isavuconazonium Sulfate Medicine Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.2 Global Isavuconazonium Sulfate Medicine Sales Value by Application
  5. 5.2.1 Global Isavuconazonium Sulfate Medicine Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Isavuconazonium Sulfate Medicine Sales Value by Application (2021-2032)
  7. 5.2.3 Global Isavuconazonium Sulfate Medicine Sales Value Share by Application (2021-2032)
6 Isavuconazonium Sulfate Medicine Regional Value Analysis
  1. 6.1 Global Isavuconazonium Sulfate Medicine Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Isavuconazonium Sulfate Medicine Sales Value by Region (2021-2032)
  3. 6.2.1 Global Isavuconazonium Sulfate Medicine Sales Value by Region: 2021-2026
  4. 6.2.2 Global Isavuconazonium Sulfate Medicine Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Isavuconazonium Sulfate Medicine Sales Value (2021-2032)
  7. 6.3.2 North America Isavuconazonium Sulfate Medicine Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Isavuconazonium Sulfate Medicine Sales Value (2021-2032)
  10. 6.4.2 Europe Isavuconazonium Sulfate Medicine Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Isavuconazonium Sulfate Medicine Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Isavuconazonium Sulfate Medicine Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Isavuconazonium Sulfate Medicine Sales Value (2021-2032)
  16. 6.6.2 South America Isavuconazonium Sulfate Medicine Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Isavuconazonium Sulfate Medicine Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Isavuconazonium Sulfate Medicine Sales Value Share by Country, 2025 VS 2032
7 Isavuconazonium Sulfate Medicine Country-level Value Analysis
  1. 7.1 Global Isavuconazonium Sulfate Medicine Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Isavuconazonium Sulfate Medicine Sales Value by Country (2021-2032)
  3. 7.2.1 Global Isavuconazonium Sulfate Medicine Sales Value by Country (2021-2026)
  4. 7.2.2 Global Isavuconazonium Sulfate Medicine Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Isavuconazonium Sulfate Medicine Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Isavuconazonium Sulfate Medicine Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Isavuconazonium Sulfate Medicine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Astellas Pharma
  2. 8.1.1 Astellas Pharma Company Information
  3. 8.1.2 Astellas Pharma Business Overview
  4. 8.1.3 Astellas Pharma Isavuconazonium Sulfate Medicine Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Astellas Pharma Isavuconazonium Sulfate Medicine Product Portfolio
  6. 8.1.5 Astellas Pharma Recent Developments
  7. 8.2 Basilea Pharmaceutica
  8. 8.2.1 Basilea Pharmaceutica Company Information
  9. 8.2.2 Basilea Pharmaceutica Business Overview
  10. 8.2.3 Basilea Pharmaceutica Isavuconazonium Sulfate Medicine Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Basilea Pharmaceutica Isavuconazonium Sulfate Medicine Product Portfolio
  12. 8.2.5 Basilea Pharmaceutica Recent Developments
  13. 8.3 Pfizer
  14. 8.3.1 Pfizer Company Information
  15. 8.3.2 Pfizer Business Overview
  16. 8.3.3 Pfizer Isavuconazonium Sulfate Medicine Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Pfizer Isavuconazonium Sulfate Medicine Product Portfolio
  18. 8.3.5 Pfizer Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst